Saturday marks the 2026 Regional Science Fair, highlighting and re-igniting a love for science, technology, engineering and ...

I do not know about you, but I often look at the weather before I leave in the morning. This helps me know what I should wear so I am prepared for anything – especially this time of the year. The ...

Biotech picks highlight cystic fibrosis drug trials, rare-disease therapies and upcoming regulatory catalysts as clinical data and approvals approach.

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

Baker Brothers’ Q4 2025 13F: portfolio jumps to $17.08B, biotech concentrated in INCY/ONC; big adds to KYMR, SMMT, KOD & ALKS ...

The Maharashtra government’s much-publicised “copy-free examination” mission during the February-March 2026 SSC and HSC board exams has suffered a major setback, with at least 14 malpractice cases ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and ...

In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people living with amyotrophic ...

The Faculty of Philosophy and Humanities at the University of Chile has opened applications for the 2026 Diploma in Latin American Critical Thought. This initiative aims to recover, update, and ...

This story was written in collaboration with Edsource’s Student Journalism Corps. 55 years ago, the Sonoma State Women’s and Gender Studies program was founded. It was the second-oldest women’s ...

Praxis Precision Medicines recently reported that, by the end of 2025, it held US$926.00 million in cash and investments, supported by a US$621.00 million financing that extends its funding runway ...

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal ...